Roche Robert P JR
SEC-identified person · CIK 1210193 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Antares Pharma, INC. ATRS | Director | filed 2013 - 2022 |
| Aratana Therapeutics, INC. PETX | Director | filed 2014 - 2019 |
| Zyla Life Sciences ZCOR | Director | filed 2016 - 2019 |
| Nupathe INC. path | Director | filed 2010 - 2014 |
| Cephalon INC CEPH | Exec. VP, WW Pharm Ops. | filed 2006 - 2009 |
| Lifecell Corp LIFC | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.